ISONIAZID Tablet Ref.[7979] Active ingredients: Isoniazid

Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: RPH Pharmaceuticals AB, Lagervägen 7, 136 50 Haninge, Sweden

Product name and form

Isoniazid Tablets BP 50mg.

Pharmaceutical Form
White biconvex uncoated tablets embossed 50 151 on one face and EVANS on the obverse.

Qualitative and quantitative composition

Isoniazid BP 50mg.

For excipients see 6.1.

Active Ingredient	Description
Isoniazid	Isoniazid is used mainly in the treatment of pulmonary tuberculosis but it appears to be effective also in the treatment of extrapulmonary lesions, including meningitis and genito-urinary disease.

List of Excipients
Lactose 170 mesh Maize starch Microcrystalline cellulose Alginic acid Magnesium stearate Purified water

Pack sizes and marketing

Pigmented polypropylene container fitted with a tamper-evident closure containing 7, 14, 21, 28, 30, 50, 56, 60, 84, 90, 100, 112, 120 or 250 tablets. Not all pack sizes may be marketed.

Marketing authorization holder

RPH Pharmaceuticals AB, Lagervägen 7, 136 50 Haninge, Sweden

Marketing authorization dates and numbers

PL 36301/0017

24/01/1991

Next: Usage >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.